Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
Agreement further extends NetraMark’s portfolio of AI-driven projects in depression and central nervous system (CNS) disorders TORONTO, March 11, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the ...
Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and ...
Purpose-built enterprise SaaS solution streamlines bioprocess workflows and accelerates digital transformation for global biopharmaceutical ...
A licensing structure assigns SteinCares end-to-end Latin America market execution while Shilpa retains development and sustained commercial supply responsibilities. The collaboration targets wider ...
Separately, Sino Biopharmaceutical said Wednesday that its subsidiary, Chia Tai Tianqing Pharmaceutical Group, has entered into an exclusive licensing agreement with French pharmaceutical giant Sanofi ...
Agreement further extends NetraMark's portfolio of AI-driven projects in depression and central nervous system (CNS) disorders TORONTO, March 11, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the ...
SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full ...
Financial support to prepare the submission of the Phase 2 clinical trial application for NFL-102 expected in mid-2026 Strengthening ...
Biopharma needs more engineers with digital manufacturing skills and experience, says Irish training organization, NIBRT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results